PMC:7219429 / 29611-29778
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T101 | 68-76 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T102 | 79-88 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T103 | 149-157 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T559 | 15-18 | Chemical | denotes | ATM | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T560 | 47-56 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T216 | 0-167 | Sentence | denotes | In conclusion, ATM and CLQ-OH have synergistic antiviral effects on SARS-CoV-2 infection, which supports the use of this combination therapy for the COVID-19 pandemic. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 823 | 15-18 | Chemical | denotes | ATM | MESH:D017963 |
| 824 | 23-29 | Chemical | denotes | CLQ-OH | |
| 830 | 73-88 | Disease | denotes | CoV-2 infection | MESH:C000657245 |
| 831 | 149-157 | Disease | denotes | COVID-19 | MESH:C000657245 |